Reversion of MDR in cancer cells by lathyrane diterpenoids has been extensively studied by investigation of their ability to modulate the transport activity of P-glycoprotein (P-gp) on different tumoral cell lines [3,7,10,14,21]. This evidence concerns the gene ABCB1 and cancer.